HomeMeetings Past Meetings 2016 SUO at the AUA Program Viewer

Past Meetings

SUO 2016 Annual Meeting At the AUA

May 07, 2016
Theme: Balancing the Risks of Overtreatment versus Undertreatment
All Sessions located in Grand Hall ABC at the Manchester Grand Hyatt San Diego unless otherwise noted

DateTimeSession
GENERAL SESSION  
07
Sat
12:30 p.m. - 12:35 p.m.
Welcome and Introductions
Program Chairs:
Stephen Anthony Boorjian, MD

Alexandre Zlotta, MD, PhD, FRCSC
07
Sat
12:35 p.m. - 12:45 p.m.
Introduction to the Whitmore Lecture
Speaker:
Robert E. Donohue, MD
07
Sat
12:45 p.m. - 1:05 p.m.
Whitmore Lecture: The Art and Business of Cancer Drug Development: Implications for Urological Oncology
Speaker:
Arie S. Belldegrun, MD, FACS
07
Sat
1:05 p.m. - 2:35 p.m.
Prostate Cancer: Be Wary of the Undertreated High-Risk Patient
Moderator:
Neil Fleshner, MD, MPH, FRCSC
07
Sat
1:05 p.m. - 1:15 p.m.
The Problem of Undertreatment of Men with High-risk Prostate Cancer in the US
Speaker:
Matthew Randal Cooperberg, MD, MPH
07
Sat
1:15 p.m. - 1:25 p.m.
Underestimating Disease Risk in the Patient Being Considered for Active Surveillance: The Implications of Race
Speaker:
Edward M. Schaeffer, MD, PhD
07
Sat
1:25 p.m. - 1:35 p.m.
Active Surveillance in Men with Gleason Pattern 4 Disease
Speaker:
Antonio Finelli, MD
07
Sat
1:35 p.m. - 1:45 p.m.
Identifying the Patient Who Benefits of Lymphadenectomy at the Time of Prostatectomy
Speaker:
James A. Eastham, MD
07
Sat
1:45 p.m. - 1:55 p.m.
Is there a Role for Definitive Local Therapy in the Setting of cN+ Disease?
Speaker:
Jason A Efstathiou, MD, DPHIL
07
Sat
1:55 p.m. - 2:05 p.m.
Radical Prostatectomy in the Setting of M1 Disease: A New Paradigm?
Speaker:
Brian F. Chapin, MD
07
Sat
2:05 p.m. - 2:15 p.m.
Evolving Role of Image-guided Treatment for Pelvic Nodal Relapse after Definitive Local Therapy
Speaker:
Alberto Briganti, MD
07
Sat
2:15 p.m. - 2:35 p.m.
Case-based Discussion of High-risk/ Advanced Disease
Moderator:
Neil Fleshner, MD, MPH, FRCSC
Panelists:
Alberto Briganti, MD

Brian F. Chapin, MD

Matthew Randal Cooperberg, MD, MPH

James A. Eastham, MD

Jason A Efstathiou, MD, DPHIL

Antonio Finelli, MD

Freddie Charles Hamdy, MD MA FRCS FRCSEd

Edward M. Schaeffer, MD, PhD
07
Sat
2:35 p.m. - 2:45 p.m.
Break
07
Sat
2:45 p.m. - 3:50 p.m.
Minimizing Morbidity while Maximizing Oncologic Efficacy in Bladder Cancer
Moderator:
Robert Scott Svatek, MD, MSCI
07
Sat
2:45 p.m. - 2:55 p.m.
Selection of TI Patients for Initial Cystectomy
Speaker:
Sam S. Chang, MD, MBA
07
Sat
2:55 p.m. - 3:05 p.m.
What to Do with BCG Refractory NMIBC When Cystectomy is Not an Option
Speaker:
Michael S. Cookson, MD, MMHC
07
Sat
3:05 p.m. - 3:15 p.m.
Bladder Cancer: What Defines an Extended Dissection and How Do We Know it Helps?
Speaker:
Eila Curlee Skinner, MD
07
Sat
3:15 p.m. - 3:25 p.m.
Is there a Role for Adjuvant Chemotherapy or Novel Targeted Agents After Radical Cystectomy?
Speaker:
Matthew I. Milowsky, MD
07
Sat
3:25 p.m. - 3:40 p.m.
Issues Surrounding Surveillance After Radical Cystectomy
07
Sat
 
Metabolic Surveillance
Speaker:
Bernard H. Bochner, MD
07
Sat
 
Oncologic Surveillance
Speaker:
George Thalmann, MD
07
Sat
3:40 p.m. - 3:50 p.m.
Questions/Cases
07
Sat
3:50 p.m. - 5:00 p.m.
Controversies in Kidney Cancer from Early to Late Stage Disease
Moderator:
Robert Guy Uzzo, MD
07
Sat
3:50 p.m. - 4:00 p.m.
Novel Imaging Modalities for the Solid Renal Mass: Are We Ready for a Radiographic Biopsy?
Speaker:
Robert Guy Uzzo, MD
07
Sat
4:00 p.m. - 4:15 p.m.
Debate: The Importance of Ischemia Versus Volume of Parenchyma During Partial Nephrectomy
07
Sat
 
Ischemia
Debater:
Scott E. Eggener, MD
07
Sat
 
Volume of Preserved Parenchyma
Debater:
Steven Charles Campbell, MD, PhD
07
Sat
4:15 p.m. - 4:25 p.m.
Moderator- Prompted Questions to Debaters
Moderator:
Robert Guy Uzzo, MD
Debaters:
Steven Charles Campbell, MD, PhD

Scott E. Eggener, MD
07
Sat
4:25 p.m. - 4:35 p.m.
Optimization of Surveillance Following Nephrectomy for RCC
Speaker:
Suzanne B. Merrill, MD
07
Sat
4:35 p.m. - 4:50 p.m.
Kidney Cancer Debate: Optimal Sequencing of Treatments for Patients with Newly Diagnosed Metastatic Kidney Cancer
07
Sat
 
Surgery First
Debater:
Christopher G. Wood, MD, FACS
07
Sat
 
Systemic Therapy First
Debater:
Bradley C. Leibovich, MD
07
Sat
4:50 p.m. - 5:00 p.m.
Moderator- Prompted Questions/ Challenging Cases to Debaters
Moderator:
Robert Guy Uzzo, MD
Debaters:
Bradley C. Leibovich, MD

Christopher G. Wood, MD, FACS
07
Sat
5:00 p.m. - 5:00 p.m.
Adjourn